# US 2025/0144058 A1 · Prevention of virus transmission with application of a composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144058 A1
- Document ID: US20250144058A1
- Status: Published application
- Kind: A1
- Application number: 18/838,021
- Filed: 2023-02-13
- Published: 2025-05-08
- Earliest claimed: 2022-02-25
- Assignees: Solventum Intellectual Properties Company
- Applicants: Solventum Intellectual Properties Company
- Inventors: Kevin D. Landgrebe; Ranjani V. Parthasarathy; Katie F. Wlaschin
- Web page: https://patentgrep.com/patent/US20250144058A1

## CPC

- A61K 31/191: having two or more hydroxy groups, e.g. gluconic acid
- A61K 9/0043: {Nose}
- A61K 31/131: acyclic
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/18: Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K 47/38: Cellulose; Derivatives thereof
- A61P 31/12: Antivirals
- A61P 31/16: for influenza or rhinoviruses
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method of preventing transmission of a virus from a mammalian subject. The method includes applying to a surface of the nasal cavity of the mammalian subject an aqueous composition. The aqueous composition includes a surfactant and a hydroxycarboxylic acid. The aqueous composition is at least substantially free of an antimicrobial agent. The aqueous composition has a viscosity of between 2,000 and 100,000 cps.

## Claims

### Claim 1

A method of preventing transmission of a virus from a mammalian subject, the method comprising,
applying to a surface of a nasal cavity of the mammalian subject an aqueous composition comprising:
a surfactant; and
a hydroxycarboxylic acid;
wherein the aqueous composition is at least substantially free of an antimicrobial agent; and
wherein the aqueous composition has a viscosity of between 2,000 and 100,000 cps.

### Claim 2 (depends on 1)

The method of claim 1, wherein the surfactant comprises a nonionic surfactant having an HLB value of at least 9.

### Claim 3 (depends on 1)

The method of claim 1, wherein the surfactant comprises an anionic or amphoteric surfactant selected from the group consisting of sulfonates, sulfates, phosphates, phosphonates, and ammonium sulfonate amphoterics.

### Claim 4 (depends on 1)

The method of claim 1, wherein the surfactant comprises an amine oxide.

### Claim 5 (depends on 1)

The method of claim 1, wherein the surfactant is present in the aqueous composition in an amount of between 0.1 and 10 wt. %, based on the total weight of the aqueous composition.

### Claim 6 (depends on 1)

The method of claim 1, wherein the hydroxycarboxylic is selected from the group consisting of lactic acid, malic acid, or citric acid.

### Claim 7 (depends on 1)

The method of claim 1, wherein hydroxycarboxylic acids are present in the aqueous composition in an amount of between 1 and 20 wt. %, based on a total weight of the aqueous composition.

### Claim 8 (depends on 1)

The method of claim 1, wherein the aqueous composition further comprises a cellulose-based thickening agent.

### Claim 9 (depends on 8)

The method of claim 8, wherein the cellulose-based thickening agent is present in an amount of between 0.5 and 10 wt. %, based on a total weight of the aqueous composition.

### Claim 10 (depends on 1)

The method of claim 1, wherein the aqueous composition has a pH of between 2.5 and 5.

### Claim 11 (depends on 1)

The method of claim 1, wherein the aqueous composition has a pH of between 3 and 3.5.

### Claim 12 (depends on 1)

The method of claim 1, wherein the aqueous composition, when subjected to the Time-Kill test, exhibits a log reduction of microbes no greater than 3 logs.

### Claim 13 (depends on 1)

The method of claim 1, wherein the step of applying to a surface of the nasal cavity comprises inserting a swab having the aqueous composition borne on a surface thereof into the nasal cavity or spraying the aqueous composition into the nasal cavity.

### Claim 14

A method of preventing transmission of a virus, the method comprising:
applying, to a mucosal tissue of a first mammalian subject and a second mammalian subject, an effective amount of an aqueous composition, wherein the first mammalian subject is substantially colonized by the virus and the second mammalian subject is not substantially colonized by the virus; and
allowing the first mammalian subject to interact with the second mammalian subject,
wherein the mucosal tissue is located in at least one of a nasopharynx, a nasal cavity, or an anterior nares, and
wherein the aqueous composition comprises:
a surfactant; and
a hydroxycarboxylic acid,
wherein the aqueous composition is substantially free of an antimicrobial agent; and wherein the aqueous composition has a viscosity of between 2,000 and 100,000 cps.

### Claim 15 (depends on 14)

The method of claim 14, wherein applying the effective amount of the composition comprises applying the composition at least 24 hours before allowing the first and second mammalian subjects to interact.
